ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Blue Trust Inc.

Blue Trust Inc. lessened its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 17.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 651 shares of the medical instruments supplier’s stock after selling 134 shares during the period. Blue Trust Inc.’s holdings in ICU Medical were worth $101,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Equitable Trust Co. increased its stake in shares of ICU Medical by 1.6% in the fourth quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier’s stock worth $822,000 after acquiring an additional 84 shares during the last quarter. Allworth Financial LP increased its stake in shares of ICU Medical by 100.0% in the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 100 shares during the last quarter. Connable Office Inc. increased its stake in shares of ICU Medical by 6.4% in the third quarter. Connable Office Inc. now owns 2,031 shares of the medical instruments supplier’s stock worth $370,000 after acquiring an additional 122 shares during the last quarter. Gagnon Securities LLC increased its stake in shares of ICU Medical by 0.5% in the fourth quarter. Gagnon Securities LLC now owns 28,881 shares of the medical instruments supplier’s stock worth $4,481,000 after acquiring an additional 137 shares during the last quarter. Finally, CIBC Asset Management Inc increased its stake in shares of ICU Medical by 9.8% in the third quarter. CIBC Asset Management Inc now owns 2,262 shares of the medical instruments supplier’s stock worth $412,000 after acquiring an additional 201 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

Insider Transactions at ICU Medical

In other ICU Medical news, COO Christian B. Voigtlander sold 1,962 shares of ICU Medical stock in a transaction on Monday, November 25th. The shares were sold at an average price of $169.08, for a total value of $331,734.96. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $162.91, for a total transaction of $1,954,920.00. Following the completion of the sale, the chief executive officer now owns 104,593 shares in the company, valued at $17,039,245.63. The trade was a 10.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 17,737 shares of company stock valued at $2,879,752 over the last three months. 6.70% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. KeyCorp increased their target price on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 13th. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. Finally, Jefferies Financial Group raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price on the stock in a research report on Wednesday, December 11th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $199.67.

ICU Medical Price Performance

ICUI opened at $157.42 on Friday. The company has a fifty day moving average price of $160.74 and a two-hundred day moving average price of $165.91. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. ICU Medical, Inc. has a 52 week low of $93.36 and a 52 week high of $196.26. The firm has a market capitalization of $3.85 billion, a PE ratio of -34.45 and a beta of 0.63.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.